GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
-$4.36M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$9.27M
2
+$8.22M
3
+$5.07M
4
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$4.49M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$3.59M

Top Sells

1
+$27.3M
2
+$14.3M
3
+$14.2M
4
MDCO
Medicines Co
MDCO
+$5.69M
5
STML
Stemline Therapeutics, Inc.
STML
+$4.2M

Sector Composition

1 Healthcare 60.74%
2 Technology 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
– –
0
27
– –
-110,566
28
– –
-1,018,627
29
– –
0
30
– –
0
31
– –
-475,200
32
– –
-150,000
33
– –
-180,752
34
– –
-769,047
35
– –
-750,000
36
– –
-75,000
37
– –
-101,235
1
2